Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B

Semin Oncol. 1987 Jun;14(2 Suppl 1):25-31.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Adult
  • Age Factors
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Clinical Trials as Topic
  • Cytarabine / administration & dosage*
  • Daunorubicin / administration & dosage
  • Drug Administration Schedule
  • Drug Evaluation
  • Humans
  • Leukemia / drug therapy*
  • Middle Aged
  • Prognosis

Substances

  • Cytarabine
  • Daunorubicin